#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Amy Kenney Email
Senior HRIS and Compensation Manager . Epizyme
How to contact Amy Kenney
Join and see Amy's contact info for free!Phone
Current Roles
Employees:
270Revenue:
$34.2MAbout
Epizyme, Inc. is a late-stage biopharmaceutical company rewriting therapy for cancer and other serious diseases through novel epigenetic medicines. Our pipeline is led by tazemetostat, an investigational agent that is an orally administered, first-in-class small molecule EZH2 inhibitor for the treatment of multiple types of hematological malignancies and genetically defined solid tumors. The company also is developing a novel G9a program with its next development candidate, EZM8266, which is targeting sickle cell disease. By focusing on the genetic drivers of disease, Epizyme's science seeks to match targeted medicines with the patients who need them.Epizyme Address
400 Technology SquareCambridge, MA
United States